Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104693123A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis route for Bcr-Abl inhibitor intermediates offering cost reduction and scalable manufacturing for pharmaceutical supply chains.